BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18676853)

  • 1. A small-molecule E2F inhibitor blocks growth in a melanoma culture model.
    Ma Y; Kurtyka CA; Boyapalle S; Sung SS; Lawrence H; Guida W; Cress WD
    Cancer Res; 2008 Aug; 68(15):6292-9. PubMed ID: 18676853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F inhibition synergizes with paclitaxel in lung cancer cell lines.
    Kurtyka CA; Chen L; Cress WD
    PLoS One; 2014; 9(5):e96357. PubMed ID: 24831239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F4 deficiency promotes drug-induced apoptosis.
    Ma Y; Freeman SN; Cress WD
    Cancer Biol Ther; 2004 Dec; 3(12):1262-9. PubMed ID: 15611646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved synthesis, resolution, absolute configuration determination and biological evaluation of HLM006474 enantiomers.
    Rosales-Hurtado M; Lebeau A; Bourouh C; Cebrian-Torrejon G; Albalat M; Jean M; Naubron JV; Annicotte JS; Benfodda Z; Meffre P
    Bioorg Med Chem Lett; 2019 Feb; 29(3):380-382. PubMed ID: 30578036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes.
    van der Sman J; Thomas NS; Lam EW
    J Biol Chem; 1999 Apr; 274(17):12009-16. PubMed ID: 10207023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity.
    Ghosh R; Nadiminty N; Fitzpatrick JE; Alworth WL; Slaga TJ; Kumar AP
    J Biol Chem; 2005 Feb; 280(7):5812-9. PubMed ID: 15574415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
    Hu XT
    Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
    Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
    Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity.
    Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI
    Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
    Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
    Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
    Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation.
    Hayashi R; Goto Y; Ikeda R; Yokoyama KK; Yoshida K
    J Biol Chem; 2006 Nov; 281(47):35633-48. PubMed ID: 16984923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.